insights_auto
Pse është rritur IDXX 3,43%?
Zhytu më thellëchevron_right
IDXX:NASDAQ
IDEXX Laboratories Inc
547,18 US$
arrow_upward
+3,43%(+18,17) 1D
547,18 US$
0,00% (0,00)
bedtimeJashtë orarit
Mbyllur: 15 tet, 4:00:01 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për IDXX...
Hap
538,34 US$
I lartë
547,83 US$
I ulët
535,28 US$
Kapitalizimi i tregut
43,11 mld
Vëllimi mesatar
520,89 mijë
Vëllimi
545,29 mijë
Raporti çmim/fitim
38,46
Maksimumi 52-javor
769,98 US$
Minimumi 52-javor
500,61 US$
Fitimet për aksion
14,23 US$
Beta
1,55
Aksionet në qarkullim
78,78 mln
Numri i punonjësve
11 mijë
Hap
538,34 US$
I lartë
547,83 US$
I ulët
535,28 US$
Kapitalizimi i tregut
43,11 mld
Vëllimi mesatar
520,89 mijë
Vëllimi
545,29 mijë
Raporti çmim/fitim
38,46
Maksimumi 52-javor
769,98 US$
Minimumi 52-javor
500,61 US$
Fitimet për aksion
14,23 US$
Beta
1,55
Aksionet në qarkullim
78,78 mln
Numri i punonjësve
11 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
GuruFocus
·
57 minuta më parë
IDEXX Laboratories Inc (IDXX) Shares Surge 3.4% -- What GF Score of 96 Tells Investors
ad-hoc-news.de
·
2 orë më parë
IDEXX Laboratories stock sits 36.51 percent below USD 747.00 target
Yahoo Finance
·
10 orë më parë
IDEXX Laboratories’ Q3 2026 Earnings: What to Expect
Yahoo Finance
·
1 ditë më parë
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts
Profili
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.
In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. Wikipedia
Rreth IDEXX Laboratories Inc
Drejtori ekzekutivJay Mazelsky
Punonjësit11 mijë
Themeluar më19 dhj 1983
SeliaWestbrook, Maine, Shtetet e Bashkuara të Amerikës
SektoriMedical device
Uebsajtiidexx.com